Samsung Electronics (KRX: 005930) is a South Korean multinational technology conglomerate headquartered in Suwon, South Korea, and one of the world's largest producers of electronic devices, semiconductors, and consumer electronics. Founded in 1969 as a subsidiary of the Samsung Group, the company has grown to become a global leader across multiple sectors, including smartphones, televisions, home appliances, and increasingly, digital health technologies. Within the context of NeuroWiki, Samsung represents a significant player in the Parkinson's disease and broader neurodegenerative disease ecosystem through its investments in wearable technology, health monitoring platforms, and artificial intelligence-driven diagnostic tools.
The company's strategic pivot toward healthcare technology reflects broader industry trends and the recognition that consumer electronics can play a transformative role in disease monitoring, clinical research, and patient care. Samsung's Galaxy Watch devices, Samsung Health platform, and proprietary BioActive sensor technology have positioned it as a leader in consumer wearables for health monitoring, with particular relevance for neurodegenerative diseases where continuous monitoring of motor and non-motor symptoms provides valuable clinical insights.
Samsung Electronics operates through multiple business divisions:
| Division | Revenue (2024) | Key Products |
|----------|---------------|--------------|
| Device eXperience | $85B | Smartphones, tablets, wearables |
| Display Solutions | $25B | OLED panels, displays |
| Harman | $10B | Automotive electronics, JBL |
| Samsung SDI | $15B | Batteries, energy storage |
The healthcare technology initiatives span across multiple divisions, with primary responsibility residing within the Device eXperience division for consumer wearables and the Samsung Advanced Institute of Technology (SAIT) for research and development.
Samsung's approach to healthcare technology encompasses three strategic pillars:
This multi-layered approach allows Samsung to address different market segments while building comprehensive health ecosystems that can integrate with clinical systems and research platforms.
Samsung Health serves as the company's primary health and wellness platform, integrating data from Galaxy Watch devices, Galaxy Ring, and third-party connected devices into a unified health dashboard. The platform has evolved from a simple activity tracker into a comprehensive health management system with features relevant to neurodegenerative disease monitoring.
Core Features
For Parkinson's disease patients and researchers, Samsung Health offers several relevant features:
Samsung provides a comprehensive developer platform through Samsung Developers Health API, enabling researchers and developers to access raw sensor data for custom applications:
API Capabilities
Researchers have utilized Samsung Health API for:
Samsung Galaxy Watch devices represent the company's flagship wearable platform, with several generations offering increasingly sophisticated health monitoring capabilities:
Galaxy Watch 4/5/6 Series
| Model | Key Health Features | Regulatory Status |
|-------|--------------------|-------------------|
| Galaxy Watch 4 | Heart rate, SpO2, body composition | FDA cleared |
| Galaxy Watch 5 | Enhanced HR, skin temperature | FDA cleared |
| Galaxy Watch 6 | ECG, blood pressure, AI insights | FDA cleared |
| Galaxy Watch Ultra | Advanced sensors, long battery | FDA cleared |
Key Sensor Technologies
BioActive Sensor [bioactive2023]
The proprietary BioActive sensor combines multiple measurement modalities:
Accelerometer and Gyroscope
Samsung Galaxy Ring, introduced in 2024, provides continuous health monitoring in a more discreet form factor:
Samsung Galaxy Watch devices have been evaluated for various Parkinson's disease motor symptom monitoring applications:
Tremor Detection
Research has demonstrated that smartwatch accelerometers can detect and quantify Parkinsonian tremor with clinically relevant accuracy [tremor2023]: